Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Hypertension. 2017 Mar 13;69(5):950–956. doi: 10.1161/HYPERTENSIONAHA.116.08952

TABLE 1. Characteristics of the Study Population.

All values reflect measurements taken when participants were maintained on a liberalized dietary sodium intake, unless otherwise indicated.

Characteristic Value
Age (years) 40.4 ± 12.4
Race/Ethnicity (%Caucasian) 72
Male Sex (%) 53
Body mass index (kg/m2) 25.7 ± 4.3
Systolic BP (mmHg) 113.8 ± 12.6
ARR (ng/dL per ng/mL/h) 15.4 ± 13.7
11.6 [6.9–25.9]
ARR ≥ 20 (ng/dL per ng/mL/h) (n/n; %) 55/210; 26
Supine Serum Aldosterone (ng/dL) 3.48 ± 1.8
2.8 [2.5–4.1]
Supine PRA (ng/mL/h) 0.38 ± 0.3
0.30 [0.13–0.49]
Supine PRA on RES (ng/mL/h) 2.88 ± 2.1
2.27 [1.2–4.2]
Standing Posture PRA on RES (ng/mL/h) 9.89 ± 6.9
8.50 [4.7–12.9]
Serum potassium (mmol/L) 4.11 ± 0.3
ΔALDOAngII 7.45 ± 5.6 (+227%)
Renal plasma flow (mL/min/1.73m2) 558 ± 132
Urinary sodium (mmol/24h) 248.3 ± 68.1
Urinary potassium (mmol/24h) 77.4 ± 26.7
Urinary sodium-to-potassium excretion ratio (mmol/mmol per 24h) 3.55 ± 1.45
Aldosterone excretion rate (mcg/24h) 8.13 ± 7.1
Range= 1.1–79.9

Data are presented as mean +/− SD for continuous variables and frequencies (%) for categorical variables. Non-normally distributed variables are also presented as median with interquartile ranges. Aldosterone excretion rate is presented as mean +/− SD and with the range of the full distribution. BP=blood pressure; ARR=aldosterone-to-renin ratio; PRA=plasma renin activity; ΔALDOAngII=the change in serum aldosterone following an infusion of angiotensin II; RES=dietary sodium restriction.